Below the 1.24 mg/L threshold, each 0.1 mg/L increase in cystatin C conferred 13.84-fold higher stroke risk (95% CI: 7.11–27.04), demonstrating exponential risk elevation in the subthreshold range. This evidence concerns the gene CST3 and stroke disorder.